Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lungs in Vitro Model Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 2D Cell Models
1.2.3 3D Cell Models
1.3 Market by Application
1.3.1 Global Lungs in Vitro Model Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Drug Discovery and Toxicology
1.3.3 3D Model Development
1.3.4 Basic Research
1.3.5 Physiological Research
1.3.6 Stem Cell Research and Regenerative Medicine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lungs in Vitro Model Market Perspective (2018-2033)
2.2 Lungs in Vitro Model Growth Trends by Region
2.2.1 Global Lungs in Vitro Model Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lungs in Vitro Model Historic Market Size by Region (2018-2023)
2.2.3 Lungs in Vitro Model Forecasted Market Size by Region (2024-2033)
2.3 Lungs in Vitro Model Market Dynamics
2.3.1 Lungs in Vitro Model Industry Trends
2.3.2 Lungs in Vitro Model Market Drivers
2.3.3 Lungs in Vitro Model Market Challenges
2.3.4 Lungs in Vitro Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lungs in Vitro Model Players by Revenue
3.1.1 Global Top Lungs in Vitro Model Players by Revenue (2018-2023)
3.1.2 Global Lungs in Vitro Model Revenue Market Share by Players (2018-2023)
3.2 Global Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lungs in Vitro Model Revenue
3.4 Global Lungs in Vitro Model Market Concentration Ratio
3.4.1 Global Lungs in Vitro Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Model Revenue in 2022
3.5 Lungs in Vitro Model Key Players Head office and Area Served
3.6 Key Players Lungs in Vitro Model Product Solution and Service
3.7 Date of Enter into Lungs in Vitro Model Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lungs in Vitro Model Breakdown Data by Type
4.1 Global Lungs in Vitro Model Historic Market Size by Type (2018-2023)
4.2 Global Lungs in Vitro Model Forecasted Market Size by Type (2024-2033)
5 Lungs in Vitro Model Breakdown Data by Application
5.1 Global Lungs in Vitro Model Historic Market Size by Application (2018-2023)
5.2 Global Lungs in Vitro Model Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lungs in Vitro Model Market Size (2018-2033)
6.2 North America Lungs in Vitro Model Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Lungs in Vitro Model Market Size by Country (2018-2023)
6.4 North America Lungs in Vitro Model Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lungs in Vitro Model Market Size (2018-2033)
7.2 Europe Lungs in Vitro Model Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Lungs in Vitro Model Market Size by Country (2018-2023)
7.4 Europe Lungs in Vitro Model Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lungs in Vitro Model Market Size (2018-2033)
8.2 Asia-Pacific Lungs in Vitro Model Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Lungs in Vitro Model Market Size by Region (2018-2023)
8.4 Asia-Pacific Lungs in Vitro Model Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lungs in Vitro Model Market Size (2018-2033)
9.2 Latin America Lungs in Vitro Model Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Lungs in Vitro Model Market Size by Country (2018-2023)
9.4 Latin America Lungs in Vitro Model Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lungs in Vitro Model Market Size (2018-2033)
10.2 Middle East & Africa Lungs in Vitro Model Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Lungs in Vitro Model Market Size by Country (2018-2023)
10.4 Middle East & Africa Lungs in Vitro Model Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ATCC
11.1.1 ATCC Company Detail
11.1.2 ATCC Business Overview
11.1.3 ATCC Lungs in Vitro Model Introduction
11.1.4 ATCC Revenue in Lungs in Vitro Model Business (2018-2023)
11.1.5 ATCC Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Lungs in Vitro Model Introduction
11.2.4 Lonza Revenue in Lungs in Vitro Model Business (2018-2023)
11.2.5 Lonza Recent Development
11.3 Epithelix
11.3.1 Epithelix Company Detail
11.3.2 Epithelix Business Overview
11.3.3 Epithelix Lungs in Vitro Model Introduction
11.3.4 Epithelix Revenue in Lungs in Vitro Model Business (2018-2023)
11.3.5 Epithelix Recent Development
11.4 Mattek
11.4.1 Mattek Company Detail
11.4.2 Mattek Business Overview
11.4.3 Mattek Lungs in Vitro Model Introduction
11.4.4 Mattek Revenue in Lungs in Vitro Model Business (2018-2023)
11.4.5 Mattek Recent Development
11.5 Emulate
11.5.1 Emulate Company Detail
11.5.2 Emulate Business Overview
11.5.3 Emulate Lungs in Vitro Model Introduction
11.5.4 Emulate Revenue in Lungs in Vitro Model Business (2018-2023)
11.5.5 Emulate Recent Development
11.6 Mimetas
11.6.1 Mimetas Company Detail
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Lungs in Vitro Model Introduction
11.6.4 Mimetas Revenue in Lungs in Vitro Model Business (2018-2023)
11.6.5 Mimetas Recent Development
11.7 Tissuse
11.7.1 Tissuse Company Detail
11.7.2 Tissuse Business Overview
11.7.3 Tissuse Lungs in Vitro Model Introduction
11.7.4 Tissuse Revenue in Lungs in Vitro Model Business (2018-2023)
11.7.5 Tissuse Recent Development
11.8 Insphero
11.8.1 Insphero Company Detail
11.8.2 Insphero Business Overview
11.8.3 Insphero Lungs in Vitro Model Introduction
11.8.4 Insphero Revenue in Lungs in Vitro Model Business (2018-2023)
11.8.5 Insphero Recent Development
11.9 Cn Bio
11.9.1 Cn Bio Company Detail
11.9.2 Cn Bio Business Overview
11.9.3 Cn Bio Lungs in Vitro Model Introduction
11.9.4 Cn Bio Revenue in Lungs in Vitro Model Business (2018-2023)
11.9.5 Cn Bio Recent Development
11.10 AlveoliX
11.10.1 AlveoliX Company Detail
11.10.2 AlveoliX Business Overview
11.10.3 AlveoliX Lungs in Vitro Model Introduction
11.10.4 AlveoliX Revenue in Lungs in Vitro Model Business (2018-2023)
11.10.5 AlveoliX Recent Development
11.11 Oncotheis
11.11.1 Oncotheis Company Detail
11.11.2 Oncotheis Business Overview
11.11.3 Oncotheis Lungs in Vitro Model Introduction
11.11.4 Oncotheis Revenue in Lungs in Vitro Model Business (2018-2023)
11.11.5 Oncotheis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lungs in Vitro Model Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of 2D Cell Models
Table 3. Key Players of 3D Cell Models
Table 4. Global Lungs in Vitro Model Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Lungs in Vitro Model Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Lungs in Vitro Model Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Lungs in Vitro Model Market Share by Region (2018-2023)
Table 8. Global Lungs in Vitro Model Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Lungs in Vitro Model Market Share by Region (2024-2033)
Table 10. Lungs in Vitro Model Market Trends
Table 11. Lungs in Vitro Model Market Drivers
Table 12. Lungs in Vitro Model Market Challenges
Table 13. Lungs in Vitro Model Market Restraints
Table 14. Global Lungs in Vitro Model Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Lungs in Vitro Model Market Share by Players (2018-2023)
Table 16. Global Top Lungs in Vitro Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2022)
Table 17. Ranking of Global Top Lungs in Vitro Model Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Lungs in Vitro Model Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lungs in Vitro Model Product Solution and Service
Table 21. Date of Enter into Lungs in Vitro Model Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lungs in Vitro Model Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Lungs in Vitro Model Revenue Market Share by Type (2018-2023)
Table 25. Global Lungs in Vitro Model Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Lungs in Vitro Model Revenue Market Share by Type (2024-2033)
Table 27. Global Lungs in Vitro Model Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Lungs in Vitro Model Revenue Market Share by Application (2018-2023)
Table 29. Global Lungs in Vitro Model Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Lungs in Vitro Model Revenue Market Share by Application (2024-2033)
Table 31. North America Lungs in Vitro Model Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Lungs in Vitro Model Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Lungs in Vitro Model Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Lungs in Vitro Model Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Lungs in Vitro Model Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Lungs in Vitro Model Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Lungs in Vitro Model Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Lungs in Vitro Model Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Lungs in Vitro Model Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Lungs in Vitro Model Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Lungs in Vitro Model Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Lungs in Vitro Model Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Lungs in Vitro Model Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Lungs in Vitro Model Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Lungs in Vitro Model Market Size by Country (2024-2033) & (US$ Million)
Table 46. ATCC Company Detail
Table 47. ATCC Business Overview
Table 48. ATCC Lungs in Vitro Model Product
Table 49. ATCC Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 50. ATCC Recent Development
Table 51. Lonza Company Detail
Table 52. Lonza Business Overview
Table 53. Lonza Lungs in Vitro Model Product
Table 54. Lonza Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Epithelix Company Detail
Table 57. Epithelix Business Overview
Table 58. Epithelix Lungs in Vitro Model Product
Table 59. Epithelix Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 60. Epithelix Recent Development
Table 61. Mattek Company Detail
Table 62. Mattek Business Overview
Table 63. Mattek Lungs in Vitro Model Product
Table 64. Mattek Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 65. Mattek Recent Development
Table 66. Emulate Company Detail
Table 67. Emulate Business Overview
Table 68. Emulate Lungs in Vitro Model Product
Table 69. Emulate Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 70. Emulate Recent Development
Table 71. Mimetas Company Detail
Table 72. Mimetas Business Overview
Table 73. Mimetas Lungs in Vitro Model Product
Table 74. Mimetas Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 75. Mimetas Recent Development
Table 76. Tissuse Company Detail
Table 77. Tissuse Business Overview
Table 78. Tissuse Lungs in Vitro Model Product
Table 79. Tissuse Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 80. Tissuse Recent Development
Table 81. Insphero Company Detail
Table 82. Insphero Business Overview
Table 83. Insphero Lungs in Vitro Model Product
Table 84. Insphero Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 85. Insphero Recent Development
Table 86. Cn Bio Company Detail
Table 87. Cn Bio Business Overview
Table 88. Cn Bio Lungs in Vitro Model Product
Table 89. Cn Bio Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 90. Cn Bio Recent Development
Table 91. AlveoliX Company Detail
Table 92. AlveoliX Business Overview
Table 93. AlveoliX Lungs in Vitro Model Product
Table 94. AlveoliX Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 95. AlveoliX Recent Development
Table 96. Oncotheis Company Detail
Table 97. Oncotheis Business Overview
Table 98. Oncotheis Lungs in Vitro Model Product
Table 99. Oncotheis Revenue in Lungs in Vitro Model Business (2018-2023) & (US$ Million)
Table 100. Oncotheis Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lungs in Vitro Model Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Lungs in Vitro Model Market Share by Type: 2022 VS 2033
Figure 3. 2D Cell Models Features
Figure 4. 3D Cell Models Features
Figure 5. Global Lungs in Vitro Model Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Lungs in Vitro Model Market Share by Application: 2022 VS 2033
Figure 7. Drug Discovery and Toxicology Case Studies
Figure 8. 3D Model Development Case Studies
Figure 9. Basic Research Case Studies
Figure 10. Physiological Research Case Studies
Figure 11. Stem Cell Research and Regenerative Medicine Case Studies
Figure 12. Lungs in Vitro Model Report Years Considered
Figure 13. Global Lungs in Vitro Model Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Lungs in Vitro Model Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Lungs in Vitro Model Market Share by Region: 2022 VS 2033
Figure 16. Global Lungs in Vitro Model Market Share by Players in 2022
Figure 17. Global Top Lungs in Vitro Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lungs in Vitro Model Revenue in 2022
Figure 19. North America Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Lungs in Vitro Model Market Share by Country (2018-2033)
Figure 21. United States Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Lungs in Vitro Model Market Share by Country (2018-2033)
Figure 25. Germany Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Lungs in Vitro Model Market Share by Region (2018-2033)
Figure 33. China Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Lungs in Vitro Model Market Share by Country (2018-2033)
Figure 41. Mexico Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Lungs in Vitro Model Market Share by Country (2018-2033)
Figure 45. Turkey Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Lungs in Vitro Model Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. ATCC Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 48. Lonza Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 49. Epithelix Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 50. Mattek Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 51. Emulate Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 52. Mimetas Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 53. Tissuse Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 54. Insphero Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 55. Cn Bio Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 56. AlveoliX Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 57. Oncotheis Revenue Growth Rate in Lungs in Vitro Model Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed